9.16.2004

September 20 to 26 is Prostate Cancer Awareness Week, Canada

September 20 to 26 is Prostate Cancer Awareness Week, Canada

Did you know?
-- prostate cancer is the most common cancer in Canadian men
-- on average, 386 Canadian men will be diagnosed with prostate cancer every week
-- death rates for prostate cancer in Canada fell by almost 15 per cent between 1991 and 2000
What The Canadian Cancer Society is doing
The Canadian Cancer Society knows that Canadians are concerned about prostate cancer... click link for more info.
[feedsfarm.com Search: cancer]

Lymphoma Awareness Day seeks to increase cancer awareness

Lymphoma Awareness Day seeks to increase cancer awareness

September 15, 2004 was the 1st Annual Worldwide Lymphoma Awareness Day... click link for more info.
[feedsfarm.com Search: cancer]

Blood Test, Better at Predicting Survival Rate of Ovarian Cancer

Blood Test, Better at Predicting Survival Rate of Ovarian Cancer
Researchers found the C-A-125 blood test to be two-and-half times more accurate than C-T scans in predicting survival among 130 women.
Abclocal.go.com - Sep 17 2004 7:21:7 GMT
[All Headline News - News and Headlines]

New method targeting hypermethylation detects ovarian cancer in the blood

New method targeting hypermethylation detects ovarian cancer in the blood

news-medical.net - Sep 16 2004 16:35:1 GMT
[All Headline News - News and Headlines]
15, 2004, issue of Cancer Research

Exercise May Beat Breast Cancer in the Long Run

Exercise May Beat Breast Cancer in the Long Run

Title: Exercise May Beat Breast Cancer in the Long Run Category: Health News Created: 9/15/04 1:55:00 AM Last Editorial Review: 9/15/04 1:55:25 AM
[feedsfarm.com Search: cancer]

New Haven newbie Ziopharm to study organic arsenic as cancer killer

New Haven newbie Ziopharm to study organic arsenic as cancer killer

Biotech startup Ziopharm Inc. in New Haven, Conn., has completed a worldwide licensing agreement with The University of Texas M. D. Anderson Cancer Center and Texas A&M University for a new class of organic ...

Phase I studies in adults with blood cancers and lymphomas are expected to begin in the first quarter of 2005. Parallel Phase I studies in solid cancers are planned for late in the second quarter.
[Cancer - Topix.net]

Decoupling The Control Of Brain Cancer Cells To Find Better Treatments

Decoupling The Control Of Brain Cancer Cells To Find Better Treatments

Most recently, O'Rourke and Gurpreet S. Kapoor, PhD, Research Associate in O'Rourke's laboratory, have discovered that two proteins sitting on the surface of cells are the interconnected switches for turning ...
[Cancer - Topix.net]
September 15 issue of Cancer Research

Health In Brief: Chemotherapy agents could damage the heart

Health In Brief: Chemotherapy agents could damage the heart

What they did: The scientists reviewed 29 anticancer drugs for cardiac toxicity, both by scouring the existing literature on the subject and reviewing their own clinical experience at M.D. Anderson.
[Cancer - Topix.net]
Yeh, E.T. et al. "Cardiovascular Complications of Cancer Therapy." Circulation. June 29, 2004, Vol. 109, No. 25, pp. 3122–31.

9.15.2004

Cannabis may have cancer busting properties

Cannabis may have cancer busting properties
A new study indicates that the chemical in cannabis that makes us stoned, delta-9-tetrahydrocannibol, might also protect us from cancer. According to researchers, delta-9-tetrahydrocannibol is able to halt the spread of gamma herpes viruses.

Gamma herpes viruses have been shown to increase one’s chances of developing Kaposis Sarcoma, Burkitts lymphoma and Hodgkins disease.

You can read about this latest study in the journal BMC Medicine
medicalnewstoday.com - Sep 15 2004 14:3:51 GMT
[All Headline News - News and Headlines]

Australia-Austrian project to fight cancer with sea sponges

Australia-Austrian project to fight cancer with sea sponges

Researchers with the Australian Institute of Marine Science (AIMS) said Wednesday they have found properties in sea sponges and some algae that attack one or two types of cancer cells while leaving healthy cells intact.
news.yahoo.com - Sep 15 2004 13:25:16 GMT
[All Headline News - News and Headlines]

9.14.2004

Other highlights in the September 15 JNCI

Other highlights in the September 15 JNCI

Other highlights in the September 15 JNCI include an examination of cancer risk among pesticide applicators exposed to atrazine, a study of alcohol consumption and the risk of bladder cancer, an assessment of how changes in tumor classification altered gastric cancer incidence, and an animal study of a potential breast cancer vaccine.
[feedsfarm.com Search: cancer]

Problems persist after prostate cancer therapy

Problems persist after prostate cancer therapy

Urinary, bowel, and sexual problems arising from surgery or external radiation treatment for localized prostate cancer persist for at least five years, a new study from the National Cancer Institute shows.

"Given uncertainty about the survival benefits of any single treatment strategy, this information may be useful for helping men make more informed treatment decisions to suit their preferences," Dr. Arnold L. Potosky, the NCI researcher who led the study told AMN Health.
[feedsfarm.com Search: cancer]

New biological principle and therapeutic goal for cancer treatment

New biological principle and therapeutic goal for cancer treatment

A group of scientists at the University of Bergen and Haukeland University Hospital made a surprising discovery when they stimulated leukaemia cells with the growth hormone GM-CSF. The reaction of the cells surprised everyone and would seem to indicate that scientists in Bergen have uncovered a new biological principle and consequently, a new therapeutic goal.

"We shouted, and expected to get one reply, but what we got was a bellow from an entire football team," says Project Leader Bjørn Tore Gjertsen, who was recently presented in the renowned American periodical Cell.
news-medical.net - Sep 14 2004 15:50:46 GMT
[All Headline News - News and Headlines]

BNCT treatment has had an excellent response in a patient with head and neck cancer

BNCT treatment has had an excellent response in a patient with head and neck cancer
A Finnish research group has been the first in the world to publish an article in which BNCT treatment has had an excellent response in a patient with head and neck cancer for whom there was no other treatment available. The case report has been published in the June issue of Radiotherapy and Oncology.
news-medical.net - Sep 15 2004 5:19:5 GMT
[All Headline News - News and Headlines]

High Risk Breast Cancer Needs MRI Detection -- Study

High Risk Breast Cancer Needs MRI Detection -- Study

CHICAGO (Reuters) - Women with a high genetic risk for breast cancer run a better chance of having it detected with magnetic resonance imaging than with mammography and other methods, researchers said on Tuesday.
The study was published in this week's Journal of the American Medical Association which also carried an editorial by two researchers at Memorial Sloan-Kettering Cancer Center in New York.
[Reuters: Health]

Testosterone May Counter HRT's Cancer Effects

Testosterone May Counter HRT's Cancer Effects

NEW YORK (Reuters Health) - When added to conventional hormone replacement therapy (HRT), testosterone may reduce the risk of breast cancer in postmenopausal women, results of a small study suggest.
[Reuters: Health]

Their findings are published in the medical journal Menopause.

9.13.2004

Many Women Get First Mammogram, Delay Further Ones

Many Women Get First Mammogram, Delay Further Ones

NEW YORK (Reuters Health) - Most women are getting their first mammogram screenings for breast cancer at the recommended age of 40, but few are returning for yearly screening, a study released Monday suggests.
[Reuters: Health]

online edition of the journal Cancer

Many Don't Disclose Foregoing Drugs, Study Shows

Many Don't Disclose Foregoing Drugs, Study Shows

CHICAGO (Reuters) - Many chronically ill patients never tell their doctor or nurse they've had to cut back on prescription drugs because they are too expensive, and many physicians never ask if the drugs are unaffordable, a study said on Monday.
[Reuters: Health]
Archives of Internal Medicine

NCI announces major commitment to nanotechnology for cancer research

NCI announces major commitment to nanotechnology for cancer research "Nanotechnology has the potential to radically increase our options for prevention, diagnosis, and treatment of cancer," said Andrew von Eschenbach, M.D., director of the National Cancer Institute. "NCI's commitment to this cancer initiative comes at a critical time. Nanotechnology supports and expands the scientific advances in genomics and proteomics and builds on our understanding of the molecular underpinnings of cancer. These are the pillars which will support progress in cancer."


medicalnewstoday.com - Sep 14 2004 7:3:13 GMT
[All Headline News - News and Headlines]

Blood test may be superior to Ct scans in predicting survival in some ovarian cancer patients

Blood test may be superior to Ct scans in predicting survival in some ovarian cancer patients

A new study shows that the CA125 blood test, which measures the level of protein produced by ovarian cancer cells in the blood, may be superior to standard imaging techniques like CT scans in predicting survival in patients with recurrent ovarian cancer. The study, to be published online September 13 in the Journal of Clinical Oncology, is the first to compare the two procedures with respect to survival.
[feedsfarm.com Search: cancer]

Cancer survivors' other medical problems poorly managed

Cancer survivors' other medical problems poorly managed

People who survive cancer are less likely to receive necessary care for a wide range of other non-cancer-related medical problems according to a new study. The study suggests that a history of cancer may cause health care providers to ignore other chronic medical ailments, such as heart disease, heart failure, diabetes, and lung disease.
[feedsfarm.com Search: cancer]
published September 13, 2004 in the online edition of CANCER

Researchers discover why mutant gene causes colon cancer

Researchers discover why mutant gene causes colon cancer

Mutations in the adenomatous polyposis coli (APC) tumor suppressor gene have been found to cause 85 percent of colon cancers. Now researchers at the University of Utah's Huntsman Cancer Institute know why. In a paper published on-line Sept. 9 in the Journal of Biological Chemistry, they explain that APC controls the conversion of dietary vitamin A into retinoic acid. If this process is impaired, colon cancer can result.
[Cancer - Topix.net]

Researchers have discovered a possible way to distinguish lethal from localized prostate cancers

Researchers have discovered a possible way to distinguish lethal from localized prostate cancers

In the September 12 advance online edition of Nature, the Hopkins researchers report that only three of 12 localized prostate tumors obtained at surgery had detectable activity of the Hedgehog signaling pathway. In contrast, all 15 samples of metastatic prostate cancers, donated at patients' deaths, had Hedgehog activity, which was 10 to 100 times higher than the highest levels seen in localized tumors. news-medical.net - Sep 13 2004 15:19:8 GMT
[All Headline News - News and Headlines]

Oil treatment for cancer patients

Oil treatment for cancer patients

Cancer patients waiting for crucial test results may be given essential oils in an effort to calm their fears. The project is being led by Laura Stirling, from the School of Acute and Continuing Care Nursing, who is also an aromatherapist. news.bbc.co.uk - Sep 13 2004 15:3:22 GMT
[All Headline News - News and Headlines]

This page is powered by Blogger. Isn't yours?